Science news articles about 'sudhir paul'

... -administered FVIII and negate its blood-clotting benefits. To combat this problem, scientists in the laboratory of Sudhir Paul, Ph.D., at The University of Texas ...

... numbered 421-433 on gp120, is now under study as a target for therapeutic intervention. Sudhir Paul, Ph.D., pathology professor ... other virus uses this trick to evade the body's defenses." Paul is the senior author on a paper about this theory in a June ...

... vaccine. Our findings open a new path toward an effective preventative and therapeutic vaccine," said Sudhir Paul, Ph.D., the study's senior ...